These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5910870)

  • 1. Heparin precipitable fraction in necrotizing vasculitis.
    Harville DD; Owen CA; Winkelmann RK
    Arch Dermatol; 1966 Mar; 93(3):287-95. PubMed ID: 5910870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin precipitable fraction (HPF) in skin diseases mostly due to vascular disorders as compared to the capillarotoxic factor].
    Lukasiak B; Wnorowski J; Kalinowska J; Klimowicz M
    Przegl Dermatol; 1973; 60(2):153-9. PubMed ID: 4791672
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disseminated lupus erythematosus].
    Ribeiro MR; Bensoussan E
    Hospital (Rio J); 1970 May; 77(5):1575-9. PubMed ID: 5311595
    [No Abstract]   [Full Text] [Related]  

  • 4. The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases.
    Millns JL; Muller SA
    Arch Dermatol; 1980 Jun; 116(6):658-63. PubMed ID: 7377802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [State of the blood coagulation system in patients with dermal and hypodermal vasculitis].
    Gol'denberg IS
    Vestn Dermatol Venerol; 1974 Feb; (2):45-8. PubMed ID: 4466171
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic rheumatic disorders ("collagen disease") in childhood: lupus erythematosus, anaphylactoid purpura, dermatomyositis, and scleroderma. I.
    Hanson V; Kornreich H
    Bull Rheum Dis; 1967 Jan; 17(5):435-40 contd. PubMed ID: 6044284
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical manifestations and the pathogenetic aspects of the hemorrhagic syndrome in systemic lupus erythematosus].
    Ivanova AV; Iakimova NIa; Tinigin PA
    Ter Arkh; 1982; 54(6):57-60. PubMed ID: 7112421
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura.
    Byrnes JJ
    Adv Intern Med; 1980; 26():131-57. PubMed ID: 7013438
    [No Abstract]   [Full Text] [Related]  

  • 10. [State of blood coagulation in hemorrhagic vasculitis in children].
    Merzliak EI
    Sov Zdravookhr Kirg; 1974; 1(0):22-5. PubMed ID: 4407604
    [No Abstract]   [Full Text] [Related]  

  • 11. [Purpose of determination of cryoglobulins in skin diseases].
    Pietrzykowska A; Rubisz-Brzezińska J
    Przegl Dermatol; 1968; 55(3):323-9. PubMed ID: 5658797
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ultrastructural data on the immune-complex nature of vascular lesions in systemic lupus erythematosus].
    Dreĭer EO; Alekberova ES; Mul'diiarov PIa; Nasonova VA
    Ter Arkh; 1980; 52(6):57-9. PubMed ID: 6447379
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies of changes in free amino acid concentrations in the blood and urine in lupus erythematosus].
    Petrescu Z; Popescu E; Petrescu G; Duda R
    Rev Med Chir Soc Med Nat Iasi; 1974 Apr; 78(2):323-8. PubMed ID: 4849781
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin precipitable fraction in hemorrhagic skin changes. II. The value of HPF determinations in purpura hyperergica (arteriolitis "allergica" Ruiter).
    Jablonska S; Rzesa G; Kalinowska J
    Dermatologica; 1966; 133(6):487-94. PubMed ID: 6007530
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient high myopia in systemic lupus erythematosus associated with anasarca.
    Ayazi S; Armstrong WL; Weinstein A
    Ann Ophthalmol; 1982 Aug; 14(8):785-7. PubMed ID: 7125476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired coagulation inhibitors. 10 cases (author's transl)].
    Alexandre P; André E; Briquel ME; Labrude P; Streiff F
    Nouv Presse Med; 1980 Oct; 9(39):2901-4. PubMed ID: 7443421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-bound tryptophan-rich protein appearing in allergic vasculitis.
    Saito T; Sugai T; Ito J
    J Invest Dermatol; 1967 Aug; 49(2):107-16. PubMed ID: 6037576
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.